title: Achalasia as a cause of congestive heart failure.
authors.affiliation: Department of Gastroenterology, New Jersey Medical School, UMDNJ, Newark, New Jersey, USA.
authors.forename: Alireza
authors.initials: A
authors.lastname: Sedarat
authors.forename: Mark J
authors.initials: MJ
authors.lastname: Sterling
authors.forename: Michael A
authors.initials: MA
authors.lastname: Fuhrman
authors.forename: William M
authors.initials: WM
authors.lastname: Lewis
authors.forename: Muhamed
authors.initials: M
authors.lastname: Saric
mesh_terms: D000369:Aged, 80 and over; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage / Q000627:therapeutic use; D003937:Diagnosis, Differential; D018450:Disease Progression; D004452:Echocardiography; D016099:Endoscopy, Gastrointestinal; D004931:Esophageal Achalasia / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D005260:Female; D005500:Follow-Up Studies; D006333:Heart Failure / Q000000981:diagnostic imaging / Q000209:etiology* / Q000503:physiopathology; D006801:Humans; D007267:Injections; D009200:Myocardial Contraction; D009465:Neuromuscular Agents / Q000008:administration & dosage / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed
chemical_list: D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A